PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement Solution
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.670
https://www.valueinhealthjournal.com/article/S1098-3015(11)02232-7/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
636
First Page :
A354
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02232-7&doi=10.1016/j.jval.2011.08.670